TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $516,648 | -65.5% | 61,800 | +2.5% | 0.02% | -64.7% |
| Q2 2023 | $1,497,852 | +52.5% | 60,300 | -7.7% | 0.07% | +44.7% |
| Q1 2023 | $982,112 | +20.7% | 65,300 | -5.1% | 0.05% | +4.4% |
| Q4 2022 | $813,904 | +317.4% | 68,800 | +109.1% | 0.04% | +275.0% |
| Q3 2022 | $195,000 | +9.6% | 32,900 | -21.7% | 0.01% | +9.1% |
| Q2 2022 | $178,000 | +9.2% | 42,000 | +145.6% | 0.01% | +37.5% |
| Q1 2022 | $163,000 | -63.6% | 17,100 | -27.5% | 0.01% | -66.7% |
| Q4 2021 | $448,000 | -23.9% | 23,600 | +33.3% | 0.02% | -29.4% |
| Q3 2021 | $589,000 | +390.8% | 17,700 | +608.0% | 0.03% | +580.0% |
| Q1 2021 | $120,000 | +15.4% | 2,500 | +25.0% | 0.01% | 0.0% |
| Q4 2020 | $104,000 | +300.0% | 2,000 | +100.0% | 0.01% | +150.0% |
| Q3 2020 | $26,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |